2024 HCPCS Code C7502
Percutaneous breast biopsies using magnetic resonance guidance, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, all lesions unilateral or bilateral (for single lesion biopsy, use appropriate code)
TAGS: using lesion lesions localization imaging appropriate single bilateral magnetic metallic placement biopsy unilateral biopsies percutaneous resonance
| Short Description | Perc bx breast lesions mr |
| Product Note | 0229 |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | January 01, 2023 |
| HCPCS Code Added Date | January 01, 2023 |
| HCPCS Pricing Indicator Code | 11 - Price established using national rvu's |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 2 - Surgery |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- C9072 - Inj, imm glob asceniv
- C9073 - Brexucabtagene autoleucel ca
- C9074 - Injection, lumasiran
- C9075 - Injection, casimersen, 10 mg
- C9076 - Lisocabtagene car pos t
- C9077 - Inj cabotegravir/rilpivirine
- C9078 - Inj, trilaciclib, 1 mg
- C9079 - Inj, evinacumab-dgnb, 5 mg
- C9080 - Inj, melphalan flufen, 1 mg
- C9081 - Idecabtagene car pos t
- C9082 - Inj dostarlimab-gxly, 100 mg
- C9083 - Inj, amivantamab-vmjw, 10 mg
- C9084 - Loncastuximab-lpyl, 0.1 mg
- C9085 - Inj avalglucosid alfa-ngpt
- C9086 - Inj, anifrolumab-fnia
- C9087 - Inj cyclophosphamd auromedic
- C9088 - Instill, bupivac and meloxic
- C9089 - Bupivacaine implant, 1 mg
- C9090 - Plasminogen, human-tvmh 1 mg
- C9091 - Sirolimus, protein-bound,1mg